• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: Abu Dhabi Stem Cells Center (ADSCC) Achieves Milestone: UAE’s First CAR-T Cell Manufactured
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > News > Abu Dhabi Stem Cells Center (ADSCC) Achieves Milestone: UAE’s First CAR-T Cell Manufactured
NewsInnovation & TechLife Style & Wellness

Abu Dhabi Stem Cells Center (ADSCC) Achieves Milestone: UAE’s First CAR-T Cell Manufactured

ME Desk
ME Desk
Published: September 22, 2023
Share
2 Min Read
ADSCC-Achieves-Milestone-with-UAEs-First-CAR-T-Cell-Treatment
Photo Credit/Abu Dhabi Stem Cells Center
SHARE

ABU DHABI: In a groundbreaking achievement, Abu Dhabi Stem Cells Center (ADSCC), a subsidiary of PureHealth and the Middle Eastโ€™s largest healthcare platform, has successfully produced the UAEโ€™s inaugural CAR-T cell. These cells mark a significant breakthrough in the treatment of leukemia, specifically in the case of an 11-year-old boy.

Contents
  • Pioneering CAR-T Cell Therapy for a Young Leukemia Patient
  • Government and Healthcare Leaders Praise the Landmark Achievement
  • Revolutionizing Cancer Treatment and Advancing Medical Science

Pioneering CAR-T Cell Therapy for a Young Leukemia Patient

Murad, an 11-year-old child, faced a relentless battle with leukemia that initially led to remission but resurfaced six months ago. Conventional chemotherapy failed to yield results, leaving CAR-T cell therapy as the last resort.

The complex procedure unfolded within ADSCCโ€™s state-of-the-art Good Manufacturing Practices (GMP) laboratoriesโ€”a rarity in the Middle East. Over five weeks, Murad underwent treatment at ADSCC, the exclusive Centre of Excellence in Hematopoietic Stem Cell Transplantation in Abu Dhabi. The approach involved genetically modifying Muradโ€™s immune cells to combat the cancer cells, extracted from his own body, before reintroducing them intravenously.

Government and Healthcare Leaders Praise the Landmark Achievement

Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health โ€“ Abu Dhabi, lauded the accomplishment. She highlighted Abu Dhabiโ€™s growing influence in global healthcare and praised its strong infrastructure, medical facilities, and skilled workforce.

Dr. Yendry Ventura, CEO of ADSCC, emphasized the significance of CAR-T therapyโ€™s local availability, acknowledging the UAEโ€™s leadership and its vision for advanced medical innovation.

Revolutionizing Cancer Treatment and Advancing Medical Science

Dr. Fatima Al Kaabi, Executive Director of Abu Dhabi Bone Marrow Transplant Program (ADBMTยฉ) at ADSCC, underlined the institutionโ€™s commitment to advancing medical science. She celebrated the milestone and solidified the UAEโ€™s role as a global medical research destination.

UAEโ€™s first CAR-T cell therapy, previously monopolized by foreign pharmaceutical companies, now stands as a beacon of hope for patients like Murad, symbolizing the UAEโ€™s position at the forefront of medical advancements and research.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article ABBOTT BROADENS ACCESS TO CUTTING-EDGE BIOSIMILARS IN KEY EMERGING MARKETS Abbott’s Strategic Partnership with mAbxience Boosts Access to Oncology and Women’s Health Biosimilars in Emerging Markets
Next Article Qatar Launches Free Annual Influenza Vaccination Campaign Ministry of Public Health Launches Annual Influenza Vaccination Campaign in Qatar

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Abu Dhabi Stem Cells Center (ADSCC) Achieves Milestone: UAE’s First CAR-T Cell Manufactured
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Abu Dhabi Stem Cells Center (ADSCC) Achieves Milestone: UAE’s First CAR-T Cell Manufactured
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?